Navigation Links
Pharmacyclics Announces Poster Presentations and Clinical Update at the 51st Annual Meeting of the American Society of Hematology
Date:11/12/2009

SUNNYVALE, Calif., Nov. 12 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. (Nasdaq: PCYC) today announced that posters related to PCI-24781 and PCI-32765 have been selected for presentation at the 51st Annual Meeting of the American Society of Hematology (ASH), December 5-8, 2009 in New Orleans, LA.

A material clinical update relating to both the PCI-24781 (HDAC Inhibitor) and PCI-32765 (BTK Inhibitor) programs will be presented at 6pm-8pm EST on Sunday, December 6, 2009 and Monday, December 7, 2009, respectively. The Company plans to issue a press release and hold a conference call related to the above items on December 8, 2009.

Poster details are as follows:

Title: Phase I Analysis of the Safety and Pharmacodynamics of the Novel Broad Spectrum Histone Deacetylase Inhibitor (HDACi) PCI-24781 in Relapsed and Refractory Lymphoma

           Date / Time:  Sunday, December 6, 2009, 6:00PM-8:00PM
           Location:  Hall E (Ernest N. Morial Convention Center)
            Poster Board II-702
           Poster Session: Lymphoma: Therapy with Biologic Agents, excluding
            Pre-Clinical Models Poster II
           Primary presenter: Dr. Andrew Evens, Northwestern University

PCI-24781 is a novel oral pan-HDACi with potent preclinical anti-tumor activity in lymphoma cell lines and models and has previously demonstrated safety and clinical benefit in solid cancers. PCI-24781 is a well tolerated pan-HDACi, including complete absence of prolonged QT abnormalities. Preliminary clinical benefit in heavily pre-treated relapsed/refractory lymphoma patients was documented in the phase I portion of this study as described in the published abstract. Twelve patients were evaluable for response. Two confirmed responses have been seen (1 complete remission, 1 partial remission), while six patien
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pharmacyclics Announces Data and Publication Characterizing Highly-Selective HDAC Inhibitor
2. Pharmacyclics Announces Preclinical Results Supporting Development of Its Novel Btk Inhibitor in Immune Mediated Diseases
3. Pharmacyclics Reports Multiple Presentations at AACR on Its HDAC and Selective HDAC Inhibitors
4. Pharmacyclics Novel Factor VIIa Inhibitor Demonstrates Potential Inhibition of Tumor Growth in Multiple Types of Cancer
5. Pharmacyclics Novel Btk Inhibitor Shows Efficacy in Preclinical Models of Rheumatoid Arthritis and Lymphoma
6. Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483
7. Pharmacyclics, Inc. Announces Closing of a Private Financing With the Principals of Pacific Biopharma Group, Ltd.
8. Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkins Lymphoma
9. Pharmacyclics announces Global Strategic Alliance with Les Laboratoires Servier
10. Pharmacyclics to Present at Merriman Curhan Fords Investor Summit 2009
11. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... 2015 RnRMarketResearch.com adds Corneal ... report to its store. This report p provides ... The report "Corneal Ulcers - Pipeline Review, H2 ... for Corneal Ulcers. Corneal Ulcers are primarily result ... viral infections & fungal infections. The symptoms of ...
(Date:2/26/2015)...  IRIDEX Corporation (NASDAQ: IRIX ) today announced ... 2014 financial results after the market closes on Thursday, ... Company will host a conference call with the investment community ... March 5, 2015 to discuss the results of the ... access the live conference call via telephone by dialing (877) ...
(Date:2/26/2015)... LATHAM, N.Y. , Feb. 26, 2015 ... support more research to fight heart disease.  Nevertheless, year ... rely on ElectroCardioGrams (EKG) as the first test to ... whether they have chest pain or not, even though ... This occurs despite the fact that doctors know, (while ...
Breaking Medicine Technology:Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 4Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 5IRIDEX Announces Fourth Quarter and Full Year 2014 Conference Call and Release Date 2National Heart Health Month In February 2
... , WASHINGTON, Nov. 4 Sanford Wittels & Heisler, ... AtriCure, Inc., a medical device company specializing in cardiac ... with the Department of Justice (DOJ) in a qui ... interest over a five-year period. , Sanford Wittels & ...
... OAKS, Calif., Nov. 4 Amgen (Nasdaq: AMGN ... its 19th annual Amgen Award for Science Teaching Excellence ... honor extraordinary science teachers at the K-12 level who ... who achieve demonstrated results in student learning in communities ...
Cached Medicine Technology:Relator's Attorneys Comment On AtriCure/DOJ Proposed Settlement 2Call for Applications: The Amgen Award for Science Teaching Excellence 2Call for Applications: The Amgen Award for Science Teaching Excellence 3
(Date:2/27/2015)... Lyophilization has important applications in the ... standard process to stabilize, store and increase the shelf ... as vaccines, antibodies, proteins, enzymes, hormones, blood plasma ... global freeze drying market was valued at $1,969.7 million ... million by 2019 at a CAGR of 6.2% during ...
(Date:2/27/2015)... 2015 DiabetesSisters, a national 501c3 ... faced by women with diabetes, is proud to ... which aims to develop the skills of 24 ... the weekend of April 24-26th in Raleigh, NC. ... of participants was made based on the applicant’s ...
(Date:2/27/2015)... Cocaine is an extreme stimulant, causing the ... hostility. In a joint effort between Australian and American ... may soon rejoice in what has been a breakthrough ... response of cocaine, according to 7 News ... that the brain is continually communicating with the immune ...
(Date:2/27/2015)... time and under budget, the doors are nearly open ... the nearly 900,000-square-foot facility makes good on Mercy’s bold ... John’s Regional Medical Center with a stronger, state-of-the-art hospital. ... after the tornado hit Joplin, which is approximately half ... and construct a similarly sized hospital,” said Ryan Felton, ...
(Date:2/27/2015)... The producers of Forbes Living are proud ... will be featured in an upcoming episode. In an ... fight to save those who fight to save us. , ... a U.S. service member has ever had to face, and ... to lost jobs, strained relationships, financial woes, and a troubled ...
Breaking Medicine News(10 mins):Health News:Lyophilization Equipment Market worth $2,655.9 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Lyophilization Equipment Market worth $2,655.9 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:DiabetesSisters Announces 2015 Leadership Institute for April 24-26, 2015 2Health News:A New Study May Have an Answer to Treating Cocaine Addiction 2Health News:A New Study May Have an Answer to Treating Cocaine Addiction 3Health News:New Hospital Built to Stand Against Nature 2Health News:New Hospital Built to Stand Against Nature 3Health News:New Hospital Built to Stand Against Nature 4Health News:Forbes Living Joins Fight against Soldier Suicide with New PSA 2Health News:Forbes Living Joins Fight against Soldier Suicide with New PSA 3Health News:Forbes Living Joins Fight against Soldier Suicide with New PSA 4
... , Patients discontinuing statin medication following an acute myocardial ... year, say researchers at McGill University and the McGill University ... issue of the European Heart Journal . , Using ... still alive three months later, Dr. Stella Daskalopoulou and colleagues ...
... Free Public Forums across U.S. and Canada on Progress and ... Promise of Mental Health Research, ... that mental health disorders are taking on their families and,communities will ... known to-date about the causes, symptoms and progression of such,illnesses as ...
... travel insurance can be,complicated, but it doesn,t have ... comparison site, coverage is made simple with the,company,s ... Team,providing a level of personal assistance rarely found ... ), Providing access to expert Customer Care ...
... the,Economic Downturn in 2008, The 45.7 Million Uninsured ... Plus the District of Columbia, DENVER, Aug. 26 ... the number of uninsured dropped by 1.3,million people, but ... workers., While the uninsured numbers dropped from 47 ...
... A new study could explain why "daddy" and "mommy" ... brain may be hard-wired to recognize certain repetition patterns. ... University of British Columbia post-doctoral fellow Judit Gervain and ... brain activities of 22 newborns (2-3 days old) when ...
... Inc. (the "Company" or "WaterPure") (OTC Bulletin Board:,WPUR) ... Atmospheric Water,Generator (AWG) patent license agreement with Everest ... license. Under the previous agreement,WaterPure was required to ... The revised terms now call for gradually escalating ...
Cached Medicine News:Health News:Heart attack patients who stop statin risk death, say McGill researchers 2Health News:NARSAD Introduces 'Healthy Minds Across America,' an International Event Recognizing the Toll of Mental Illness, on Sunday, Sept. 14 2Health News:NARSAD Introduces 'Healthy Minds Across America,' an International Event Recognizing the Toll of Mental Illness, on Sunday, Sept. 14 3Health News:InsureMyTrip.com's Expert Customer Care Team Takes the Guesswork Out of Buying Travel Insurance 2Health News:Number of Uninsured Decreased in 2007 But Census Report Shows Growing Health Coverage Problems 2Health News:UBC scientist unveils secret of newborn's first words 2Health News:WaterPure International, Inc. and Everest Water Ltd. Revise Payment Terms of Patent License to Produce Water From Air 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: